Priority Date: 21.05.10 (US 20100346943P)

SUBSTITUTED SEVEN-MEMBERED HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES

  • Application ID: EP11784011
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. is specialized in C07. Merck & Co. Inc. is specialised in C07 (ORGANIC CHEMISTRY). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 21.05.2010 - Priority Date (US 20100346943P)
  • 24.11.2011 - Publication A1 (WO2011146358)
  • 27.03.2013 - Publication A1 (EP2571876)
  • 07.09.2016 - Publication B1 (EP2571876)

IPC Classification